KCM
ROIV icon

Kennedy Capital Management’s Roivant Sciences ROIV Stock Holding History

Kennedy Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.79M Buy
163,737
+41,840
+34% +$1.24M 0.1% 301
2026
Q1 		$3.38M Buy
121,897
+10,002
+9% +$257K 0.07% 356
2025
Q4 		$2.43M Buy
111,895
+2,324
+2% +$45.9K 0.05% 402
2025
Q3 		$1.66M Buy
109,571
+53,869
+97% +$667K 0.04% 463
2025
Q2 		$628K Buy
55,702
+2,109
+4% +$22.9K 0.02% 535
2025
Q1 		$541K Buy
53,593
+685
+1% +$7.41K 0.01% 577
2024
Q4 		$626K Buy
52,908
+9,801
+23% +$116K 0.01% 628
2024
Q3 		$497K Buy
43,107
+6,194
+17% +$70.5K 0.01% 636
2024
Q2 		$390K Buy
36,913
+10,717
+41% +$117K 0.01% 650
2024
Q1 		$276K Buy
+26,196
New +$282K 0.01% 681

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Kennedy Capital Management's ROIV Position: Q2 2026 in Review

Kennedy Capital Management increased its Roivant Sciences (ROIV) stake by 34% in Q2 2026, buying an estimated $1.24M and bringing the position to 163,737 shares worth $5.79M. The position accounts for 0.1% of the portfolio, ranked #301.

Kennedy Capital Management first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Kennedy Capital Management held 163,737 shares of Roivant Sciences worth $5.79M as of Q2 2026.
  • Kennedy Capital Management bought 41,840 Roivant Sciences shares in Q2 2026, an estimated $1.24M.
  • Roivant Sciences made up 0.1% of Kennedy Capital Management's portfolio in Q2 2026, its #301 holding.
  • Kennedy Capital Management first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.